COMMUNIQUÉS West-GlobeNewswire

VALNEVA reçoit le statut de "Fast Track" de la FDA pour son candidat vaccin contre le Chikungunya
21/12/2018
Valneva reçoit le statut de "Fast Track" de la FDA pour son candidat vaccin contre le Chikungunya Saint-Herblain (France), 21 décembre 2018 -Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie développant [...]
Merger between Eckert & Ziegler BEBIG SA and Eckert & Ziegler Strahlen- und Medizintechnik AG - Announcement of the approval of the merger by the Extraordinary General Shareholders' Meeting of BEBIG.
21/12/2018
Press release REGULATED INFORMATION Seneffe, Belgium, December 21, 2018. Shareholders' general meeting The EGM of BEBIG approved on 21 December 2018 (i) the modification of the financial year of BEBIG and (ii) the cross [...]
Fusion entre Eckert & Ziegler BEBIG SA (BEBIG) et Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) - Annonce de l'approbation de la fusion par l'assemblée générale extraordinaire de BEBIG.
21/12/2018
Communiqué de presse Information reglementée Seneffe, Belgique, 21 décembre 2018. Assemblée générale des actionnaires L'AGE de BEBIG a approuvé le 21 décembre 2018 (i) la modification de l'exercice social de BEBIG et ( [...]
Director Declaration
21/12/2018
Director Declaration December 21, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Ian Clark, Non-Executive Director of the Company, is a Non-Executive Director of Guardant Health, Inc which [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
21/12/2018
FIT Biotech Oy Company release December 21, 2018 at 05:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
AVROBIO, Inc. Added to NASDAQ Biotechnology Index
21/12/2018
CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ: AVRO), (“The Company”) a Phase 2 clinical-stage gene therapy company, today announced that the Company has been selected for addition to the [...]
PSIQ Now Expanding CBD Operations Domestically and Internationally Amid Successful Passage of 2018 Farm Bill
21/12/2018
SUNRISE, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces it is thrilled to announce the federal legalization of Hemp farming in the U.S., allowing PSIQ to aggressively expand [...]
Veritas Pharma Makes Strategic Investment in Cannabis Production for Future Cannevert R&D Needs
21/12/2018
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that the Company has entered into a [...]
EBRP, EBRF and other Global EB Charities Collaborate to Announce $1 Million Award for EB Simplex
21/12/2018
EB Research Partnership, EB Research Foundation, the Oros Family and EB Medical Research Foundation, join together to accelerate treatments and cures for EB Simplex. Proposals must be submitted by January 25, 2019 NEW [...]
NRC Health Trends Report Uncovers the Forces Shaping Healthcare Consumerism
21/12/2018
Report Compiles Patient Feedback and Expert Insights; Offers Recommendations to Address 2019 Challenges LINCOLN, Neb., Dec. 21, 2018 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of in-depth customer [...]
HMS to Present at the J.P. Morgan 37th Annual Healthcare Conference
21/12/2018
IRVING, Texas, Dec. 21, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp (NASDAQ:HMSY) today announced that Bill Lucia, Chairman and CEO, will make a presentation at the J.P. Morgan 37th Annual Healthcare Conference at 11:00 [...]
Weekend Unlimited Inc. Announces Appointment of President & CEO -- CFN Media
21/12/2018
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
International Cannabis Corp. Bolstering European Supply Chain -- CFN Media
21/12/2018
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Obalon Announces FDA Approval of Obalon Navigation System
21/12/2018
Eliminates the Need for X-Ray when Placing the Obalon Swallowable, Gas-Filled Balloon SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology [...]
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors -- CFN Media
21/12/2018
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Planet 13 Revenue Soars 63% as Las Vegas Takes Off -- CFN Media
21/12/2018
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Aleafia-Emblem Merger Creates Canada’s Largest Network of Clinics -- CFN Media
21/12/2018
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Gabriella's Kitchen Adding Seasoned Executives To The Board -- CFN Media
21/12/2018
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Aptevo Therapeutics Announces Up To $35 Million Common Stock Purchase Agreement With Lincoln Park Capital
21/12/2018
Provides Opportunistic Capital of up to $35 Million to Aptevo During the 36-month Term of the Agreement SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused [...]

Pages